Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines

被引:62
|
作者
Nakanishi, Y [1 ]
Kamijo, R [1 ]
Takizawa, K [1 ]
Hatori, M [1 ]
Nagumo, M [1 ]
机构
[1] Showa Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Ota Ku, Tokyo 1458515, Japan
关键词
U-937; ML-1; COX-2; inhibitor; NS-398; nabumetone; proliferation; differentiation; G0/G1; arrest;
D O I
10.1016/S0959-8049(01)00160-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostaglandins (PG) are known to play important roles in the proliferation and differentiation of leukaemia cells. The effect of the inhibitors of cyclooxygenase-2 (COX-2), a rate-limiting enzyme for the synthesis of PG, on the proliferation and differentiation of leukaemia cell lines was investigated. COX-2 inhibitors, NS-398 and nabumetone, suppressed the proliferation of U-937 and ML-1 cells by inducing a G0/G1 cell-cycle arrest. Cell-cycle arrest induced by these COX-2 inhibitors was not associated with an upregulation of the cyclin-dependent kinase inhibitors. COX-2 inhibitors also inhibited the differentiation of these cells induced by interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and retinoic acid (RA). Treatment with NS-398 did not suppress the levels of PGs produced by these cells. Although COX-2 antisense oligonucleotide showed a similar inhibitory effect on these cells, its inhibitory effect was smaller than that of NS-398, These results suggest that COX-2 inhibitors may suppress the proliferation and differentiation of leukaemia cells both via COX-2-dependent and -independent pathways. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1570 / 1578
页数:9
相关论文
共 50 条
  • [11] The Search for Cyclooxygenase-2 (COX-2) Inhibitors for the Treatment of Inflammation Disease: An in-silico Study
    Ruslin, Ruslin
    Yamin, Yamin
    Kasmawati, Henny
    Mangrura, Samuel
    Kadidae, Laode
    Alroem, Armid
    Arba, Muhammad
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2022, 15 : 783 - 791
  • [12] Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events
    Mukherjee, D
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (05) : 817 - 821
  • [13] Comparative molecular field analysis of selective cyclooxygenase-2 (COX-2) inhibitors
    Marot, C
    Chavatte, P
    Lesieur, D
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 2000, 19 (02): : 127 - 134
  • [14] Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor
    Hu, KQ
    Yu, CH
    Mineyama, Y
    McCracken, JD
    Hillebrand, DJ
    Hasan, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 22 (04) : 757 - 763
  • [15] Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
    Westwell-Roper, Clara
    Stewart, S. Evelyn
    FRONTIERS IN PSYCHIATRY, 2020, 11
  • [16] Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition
    Gudrun Totzke
    Klaus Schulze-Osthoff
    Reiner U Jänicke
    Oncogene, 2003, 22 : 8021 - 8030
  • [17] Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2
    Ohtsu, Nao
    Takaoka, Kazuki
    Segawa, Emi
    Hashitani, Susumu
    Noguchi, Kazuma
    Kishimoto, Hiromitsu
    Urade, Masahiro
    ONCOLOGY REPORTS, 2010, 24 (01) : 31 - 36
  • [18] Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition
    Totzke, G
    Schulze-Osthoff, K
    Jänicke, RU
    ONCOGENE, 2003, 22 (39) : 8021 - 8030
  • [19] Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398
    Yu, HP
    Shi, LY
    Lu, WH
    Su, YH
    Li, YY
    Xu, SQ
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (06) : 638 - 642
  • [20] Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma
    Onguru, Onder
    Gamsizkan, Mehmet
    Ulutin, Cuneyt
    Gunhan, Omer
    NEUROPATHOLOGY, 2008, 28 (01) : 29 - 34